Background: The aim of the present study was to investigate whether there were differences in neuroradiological features, including white-matter lesions and gray-matter volumes, between patients with lacunar infarction with and without mild cognitive impairment of the vascular type (MCI-V). Methods: A total of 40 patients with lacunar infarction were studied within 1 month after stroke. Results: MCI-V was found in 22 patients, who in comparison with patients without cognitive impairment were significantly older and had fewer years of formal education. MRI subcortical hyperintensities especially in the basal ganglia (putamen and thalamus) were significantly more frequent in the MCI-V group. In the voxel-based morphometric study, patients with MCI-V showed more atrophy bilaterally in the middle temporal gyrus, right and left frontal and posterior bilateral occipitoparietal regions including the posterior cingulate as well as in the cerebellum. A region of interest analysis restricted to the parahippocampi and hippocampi showed further reduced bilateral parahippocampal gyrus and right hippocampus volume reductions in this group of patients. Finally, the amount of white-matter lesions among MCI-V showed negative correlations with gray-matter volume in frontal and temporal areas as well as with the thalamus and mesencephalon. Conclusions: The present findings provide support for an anatomical substrate of the MCI entity in patients with lacunar infarction. Both gray- and white-matter changes seem to contribute to the cognitive impairment of such patients.

1.
Frisoni GB, Galluzzi S, Bresciani L, Zanetti O, Geroldi C: Mild cognitive impairment with subcortical vascular features: clinical characteristics and outcome. J Neurol 2002;249:1423–1432.
2.
Bowler JV, Hachinski V: Vascular cognitive impairment – A new concept; in Bowler JV, Hachinski V (eds): Vascular Cognitive Impairment: Preventable Dementia. Oxford, Oxford University Press, 2002, pp 321–327.
3.
Desmond DW, Moroney JT, Sano M: Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke2002;33:2254–2260.
4.
Laakso MP, Partanen K, Riekkinen P, Lehtovirta M, Helkala EL, Hallikainen M, Hanninen T, Vainio P, Soininen H: Hippocampal volumes in Alzheimer’s disease, Parkinson’s disease with and without dementia, and in vascular dementia: an MRI study. Neurology 1996;46:678–681.
5.
Fein G, Di Sclafani V, Tanabe J, Cardenas V, Weiner MW, Jagust WJ, Reed BR, Norman D, Schuff N, Kusdra L, Greenfield T, Chui HC: Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 2000;55:1626–1635.
6.
Mungas D, Jagust WJ, Reed BR, Kramer JH, Weiner MW, Schuff N, Norman D, Mack WJ, Willis L, Chui HC: MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer’s disease. Neurology 2001;57:2229–2235.
7.
Fisher CM: Lacunar strokes and infarcts: a review. Neurology 1982;32:871–876.
8.
van Zandvoort MJ, De Haan EH, Kappelle LJ: Chronic cognitive disturbances after a single supratentorial lacunar infarct. Neuropsychiatry Neuropsychol Behav Neurol 2001;14:98–102.
9.
Takashima Y, Yao H, Koga H, Endo K, Matsumoto T, Uchino A, Sadanaga-Akiyoshi F, Yuzuriha T, Kuroda Y: Frontal lobe dysfunction caused by multiple lacunar infarction in community-dwelling elderly subjects. J Neurol Sci 2003;214:37–41.
10.
van Zandvoort MJ, van der Grond J, Kappelle LJ, Haan EHF: Cognitive deficits and changes in neurometabolites after a lacunar infarct. J Neurol 2005;252:183–190.
11.
Arboix A, Bell Y, García-Eroles L, Massons J, Comes E, Balcells M, Targa C: Clinical study of 35 patients with dysarthria-clumsy hand syndrome. J Neurol Neurosurg Psychiatry 2004;75:231–234.
12.
Arboix A, López-Grau M, Casasnovas L, Garcia-Eroles L, Massons J, Balcells M: Clinical study of 39 patients with atypical lacunar syndrome.J Neurol Neurosurg Psychiatry 2006;77:381–384.
13.
Arboix A, Morcillo C, García-Eroles L, Oliveres M, Massons J, Targa C: Different vascular risk factor profiles in ischemic stroke subtypes. The Sagrat Cor Hospital of Barcelona Stroke Registry. Acta Neurol Scand 2000;102:264–270.
14.
Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen EG: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303–308.
15.
Spreen O, Strauss E: A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, ed 2. New York, Oxford University Press, 1998.
16.
Wechsler D: WAIS-III Escala de Inteligencia de Wechsler para Adultos III (Spanish edition). Barcelona, TEA Ediciones, 1997–1998.
17.
Peña-Casanova J: Programa integrado de exploración neuropsicológica. Test Barcelona Revisado. Barcelona, Masson, 2004–2005.
18.
Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJ, Vermersch P, Steinling M, Valk J: A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993;114:7–12.
19.
Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS: A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001;14:21–36.
20.
Yamamoto Y, Akiguchi I, Oiwa K, Hayashi M, Ohara T, Ozasa K: The relationship between 24-hour blood pressure readings, subcortical ischemic lesions and vascular dementia. Cerebrovasc Dis 2005;19:302–308.
21.
Loeb C, Gandolfo C, Croce R, Conti M: Dementia associated with lacunar infarction. Stroke 1992;23:1225–1229.
22.
Pantoni L, Basile AM, Romanelli M, Piccini C, Sarti C, Nencini P, Inzitari D: Abulia and cognitive impairment in two patients with capsular genu infarct. Acta Neurol Scand 2001;104:185–190.
23.
Corbett A, Bennett H, Kos S: Cognitive dysfunction following subcortical infarction. Arch Neurol1994;51:999–1007.
24.
Jokinen H, Kalska H, Mäntylä R, Pohjasvaara T, Ylikoski R, Hietanen M, Salonen O, Kaste M, Erkinjuntti T:Cognitive profile of subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry2006;77:28–33.
25.
Udaka F, Sawada H, Kameyama M: White matter lesions and dementia: MRI-pathological correlation. Ann NY Acad Sci 2002;977:411–415.
26.
Tatemichi TK, Desmond DW, Prohovnik I, Cross DT, Gropen TI, Mohr JP, Stern Y: Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome? Neurology 1992;42:1966–1979.
27.
Gold G, Kövari E, Herrmann FR, Canuto A, Hof PR, Michel JP, Bouras C, Giannakopoulos P: Cognitive consequences of thalamic, basal ganglia, and deep white matter lacunes in brain aging and dementia. Stroke2005;36:1184–1188.
28.
Kwan LT, Reed BR, Eberling JL, Schuff N, Tanabe J, Norman D, Weiner MW, Jagust WJ: Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function. Arch Neurol 1999;56:809–814.
29.
Reed BR, Eberling JL, Mungas D, Weiner M, Kramer JH, Jagust WJ: Effects of white matter lesions and lacunes on cortical function. Arch Neurol 2004;561:1545–1550.
30.
Buckner RL, Snyder AZ, Shannon BJ, La Rossa G, Sachs R, Fotenos AF, Sheline Yl, Klunk WE, Mathis CA, Morris JC, Mintun MA: Molecular, structural, and functional characterization of Alzheimer’s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 2005;34:7709–7717.
31.
Konishi S, Asari T, Jimura K, Chikazoe J, Miyashita Y: Activation shift from medial to lateral temporal cortex associated with recency judgements following impoverished encoding. Cereb Cortex 2006;16:469–474.
32.
Gilboa A, Ramirez J, Kohler S, Westmacott S, Black SE, Moscovitch M: Retrieval of autobiographical memory in Alzheimer’s disease: relation to volumes of medial temporal lobe and other structures. Hippocampus 2005;15:535–550.
33.
Mungas D, Reed BR, Jagust WJ, De Carli C, Mack WJ, Kramer JH, Weiner MW, Schuff N, Chui HC: Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology 2002;59:867–873.
34.
Mok V, Chang C, Wong A, Lam WWM, Richards PS, Wong KT, Wong KT: Neuroimaging determinants of cognitive performances in stroke associated with small vessel disease. J Neuroimag 2005;15:129–137.
35.
Zekry D, Duyckaerts C, Moulias R, Belmin J, Geoffre C, Herrmann F, Hauw FF: Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly. Acta Neuropathol (Berl) 2002;103:481–487.
36.
Du AT, Schuff N, Chao LL, Kornak J, Ezekiel F, Jagust WJ, Kramer JH, Reed BR, Miller BL, Norman D, Chui HC, Weiner MW: White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy. Neurobiol Aging 2005;26:553–559.
37.
van der Flier WM, van Straaten EC, Barkhof F, Ferro JM, Pantoni L, Basile AM, Inzitari D, Erkinjuntti T, Wahlund LO, Rostrup E, Schmidt R, Fazekas F, Scheltens P, on behalf of the LADIS study group: Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study. J Neurol Neurosurg Psychiatry 2005;76:1497–1500.
38.
van Straaten EC, Fazekas F, Rostrup E, Scheltens P, Schmidt R, Pantoni L, Inzitari D, Waldemar G, Erkinjuntti T, Mantlyla R, Wahlund LO, Barkhof F, LADIS Group: Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke 2006;37:836–840.
39.
van den Heuvel DM, ten Dam VH, de Craen AJ, Admiraal-Behloul F, van Es AC, Palm WM, Split A, Bollen EL, Blauw GJ, Launer L, Westendorp RG, van Buchem MA, PROSPER Study Group: Measuring longitudinal white matter changes: comparison of a visual rating scale with a volumetric measurement. Am J Neuroradiol 2006;27:875–878.
40.
O’Sullivan M, Morris RG, Huckstep B, Jones DK, Williams SCR, Markus HS: Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry 2004;75:441–447.
41.
O’Sullivan M, Singhal S, Charlton R, Markus HS: Diffusion tensor imaging of thalamus correlates with cognition in CADASIL without dementia. Neurology 2004;62:702–707.
42.
Pennanen C, Testa C, Laakso MP, Hallikainen M, Helkala EL, Hänninen T, Kivipelto M, Könönen M, Nissinen A, Tervo S, Vanhanen M, Vanninen R, Frisoni GB, Soininen H: A voxel based morphometry study on mild cognitive impairment. J Neurol Neurosurg Psychiatry 2005;76:11–14.
43.
Karas GB, Scheltens P, Rombouts SA, Visser PJ, van Schijndel RA, Fox NC, Barkhof F: Global and local gray matter loss in mild cognitive impairment and Alzheimer’s disease. Neuroimage 2004;23:708–716.
44.
Chetelat G, Desgranges B, De La Sayette V, Viader F, Eustache F, Baron JC: Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport2002;13:1939–1943.
45.
Chetelat G, Landeau B, Eustache F, Mezenge F, Viader F, de La Sayette V, Desgranges B, Baron JC: Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage 2005;27:934–946.
46.
Kril JJ, Patel S, Harding AJ, Halliday GM: Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss.J Neurol Neurosurg Psychiatry 2002;72:747–751.
47.
Zarow C, Vinters HV, Ellis WG, Weiner MW, Mungas D, White L, Chui HC: Correlates of hippocampal neuron number in Alzheimer’s disease and ischemic vascular dementia. Ann Neurol 2005;57:869–903.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.